# Artivion Inc. (AORT)

Source: https://www.quantisnow.com/company/AORT
Generated: 2026-11-16T22:14:08.905Z

- Ticker: AORT
- Exchange: NYSE
- Sector: Health Care
- Industry: Medical/Dental Instruments
- SEC CIK: 0000784199
- Website: https://artivion.com

## About

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.

## Latest AORT news and filings

- 2026-11-06 17:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Artivion Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-artivion-inc-6778497)
- 2026-11-05 21:07 UTC [SEC Form 8-K] [Artivion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/artivion-inc-filed-sec-form-8-k-results-of-operations-and-6776334)
- 2026-11-05 21:05 UTC [Earnings] [Artivion Reports Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/artivion-reports-third-quarter-2026-financial-results-6776088)
- 2026-10-28 20:10 UTC [Conference Announcement] [Artivion to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/artivion-to-participate-in-upcoming-investor-conferences-6761319)
- 2026-10-22 20:10 UTC [Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/artivion-announces-release-date-and-teleconference-call-details-for-third-6755130)
- 2026-10-20 11:52 UTC [Analyst Coverage Initiated] [Jefferies initiated coverage on Artivion with a new price target](https://www.quantisnow.com/insight/jefferies-initiated-coverage-on-artivion-with-a-new-price-target-6751461)
- 2026-09-11 21:28 UTC [SEC Form 4] [SVP, Regulatory and Quality Green Andrew M sold $286,656 worth of shares (11,480 units at $24.97), decreasing direct ownership by 22% to 40,160 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-regulatory-and-quality-green-andrew-m-sold-286656-worth-6713335)
- 2026-09-04 18:15 UTC [SEC Form 4] [SVP, Regulatory and Quality Green Andrew M sold $216,337 worth of shares (8,003 units at $27.03), decreasing direct ownership by 13% to 51,640 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-regulatory-and-quality-green-andrew-m-sold-216337-worth-6706570)
- 2026-08-20 18:11 UTC [SEC Form 4] [President & CEO Mackin James P sold $2,026,850 worth of shares (70,000 units at $28.95), decreasing direct ownership by 7% to 877,275 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ceo-mackin-james-p-sold-2026850-worth-of-shares-6689857)
- 2026-08-17 19:18 UTC [SEC Form 4] [SVP, Regulatory and Quality Green Andrew M sold $17,586 worth of shares (616 units at $28.55), decreasing direct ownership by 1% to 59,643 units (SEC Form 4) to satisfy withholding tax](https://www.quantisnow.com/insight/svp-regulatory-and-quality-green-andrew-m-sold-17586-worth-6684822)
- 2026-08-17 19:17 UTC [SEC Form 4] [EVP, COO, CFO & Treasurer Berry Lance A sold $20,413 worth of shares (715 units at $28.55), decreasing direct ownership by 0.34% to 210,112 units (SEC Form 4) (tax liability)](https://www.quantisnow.com/insight/evp-coo-cfo-treasurer-berry-lance-a-sold-20413-worth-6684820)
- 2026-08-12 21:51 UTC [SEC Form 4] [SVP, General Counsel Holloway Jean F sold $27,835 worth of shares (977 units at $28.49), decreasing direct ownership by 0.53% to 184,118 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-general-counsel-holloway-jean-f-sold-27835-worth-of-6678710)
- 2026-08-07 17:57 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Artivion Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-artivion-inc-6671243)
- 2026-08-06 20:08 UTC [SEC Form 8-K] [Artivion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/artivion-inc-filed-sec-form-8-k-results-of-operations-and-6668959)
- 2026-08-06 20:05 UTC [Earnings Date] [Artivion Reports Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/artivion-reports-second-quarter-2026-financial-results-6668782)
- 2026-08-06 14:14 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Artivion Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-artivion-inc-6667938)
- 2026-07-28 20:10 UTC [Conference Announcement] [Artivion to Participate in Upcoming Investor Conferences](https://www.quantisnow.com/insight/artivion-to-participate-in-upcoming-investor-conferences-6651486)
- 2026-07-23 20:10 UTC [Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/artivion-announces-release-date-and-teleconference-call-details-for-second-6647062)
- 2026-06-29 11:00 UTC [Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis](https://www.quantisnow.com/insight/artivion-announces-us-fda-approval-of-the-amds-hybrid-prosthesis-6618193)
- 2026-06-15 15:28 UTC [SEC Form 4] [SVP, Regulatory and Quality Green Andrew M exercised 44,001 shares at a strike of $13.39 and sold $910,739 worth of shares (44,001 units at $20.70) as part of a pre-agreed trading plan (SEC Form 4)](https://www.quantisnow.com/insight/svp-regulatory-and-quality-green-andrew-m-exercised-44001-shares-6602226)
- 2026-06-10 20:10 UTC [Conference Announcement] [Artivion to Participate in the 2026 Truist Securities MedTech Conference](https://www.quantisnow.com/insight/artivion-to-participate-in-the-2026-truist-securities-medtech-conference-6597108)
- 2026-06-08 21:51 UTC [SEC Form 3] [New insider Green Andrew M claimed ownership of 60,259 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-green-andrew-m-claimed-ownership-of-60259-shares-6594032)
- 2026-06-04 20:50 UTC [SEC Form 4] [Director Semedo Anthony B. disposed of 6,325 shares and acquired 6,325 shares, decreasing direct ownership by 13% to 40,635 units (SEC Form 4)](https://www.quantisnow.com/insight/director-semedo-anthony-b-disposed-of-6325-shares-and-acquired-6589806)
- 2026-05-21 16:34 UTC [SEC Form SD filed by Artivion Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-artivion-inc-6566874)
- 2026-05-21 01:15 UTC [SEC Form 4] [Amendment: Director Borgstrom Marna P was granted 7,576 shares, increasing direct ownership by 15% to 56,664 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-borgstrom-marna-p-was-granted-7576-shares-increasing-6566086)
- 2026-05-21 00:37 UTC [SEC Form 4] [Director Semedo Anthony B. was granted 7,576 shares, increasing direct ownership by 19% to 46,960 units (SEC Form 4)](https://www.quantisnow.com/insight/director-semedo-anthony-b-was-granted-7576-shares-increasing-direct-6566051)
- 2026-05-21 00:35 UTC [SEC Form 4] [Director Salveson Jon W was granted 7,576 shares, increasing direct ownership by 6% to 137,416 units (SEC Form 4)](https://www.quantisnow.com/insight/director-salveson-jon-w-was-granted-7576-shares-increasing-direct-6566049)
- 2026-05-21 00:33 UTC [SEC Form 4] [Director Hoff Elizabeth A was granted 7,576 shares, increasing direct ownership by 28% to 34,765 units (SEC Form 4)](https://www.quantisnow.com/insight/director-hoff-elizabeth-a-was-granted-7576-shares-increasing-direct-6566035)
- 2026-05-21 00:32 UTC [SEC Form 4] [Director Burbank Jeffrey H was granted 7,576 shares, increasing direct ownership by 14% to 61,372 units (SEC Form 4)](https://www.quantisnow.com/insight/director-burbank-jeffrey-h-was-granted-7576-shares-increasing-direct-6566033)
- 2026-05-21 00:30 UTC [SEC Form 4] [Director Bullock James was granted 7,576 shares, increasing direct ownership by 11% to 76,223 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bullock-james-was-granted-7576-shares-increasing-direct-ownership-6566029)
- 2026-05-21 00:28 UTC [SEC Form 4] [Director Bevevino Daniel J was granted 7,576 shares, increasing direct ownership by 5% to 157,637 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bevevino-daniel-j-was-granted-7576-shares-increasing-direct-6566025)
- 2026-05-21 00:26 UTC [SEC Form 4] [Director Ackerman Thomas F was granted 7,576 shares, increasing direct ownership by 5% to 157,472 units (SEC Form 4)](https://www.quantisnow.com/insight/director-ackerman-thomas-f-was-granted-7576-shares-increasing-direct-6566022)
- 2026-05-20 01:59 UTC [SEC Form 4] [Director Borgstrom Marna P was granted 7,850 shares, increasing direct ownership by 16% to 56,938 units (SEC Form 4)](https://www.quantisnow.com/insight/director-borgstrom-marna-p-was-granted-7850-shares-increasing-direct-6564073)
- 2026-05-18 11:06 UTC [SEC Form 8-K] [Artivion Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/artivion-inc-filed-sec-form-8-k-regulation-fd-disclosure-other-6559055)
- 2026-05-18 11:05 UTC [Public Offering] [Endospan Announces Closing of Acquisition by Artivion, Inc., Following FDA PMA Approval of the NEXUS® Aortic Arch System](https://www.quantisnow.com/insight/endospan-announces-closing-of-acquisition-by-artivion-inc-following-fda-6559049)
- 2026-05-18 11:00 UTC [Mergers & Acquisitions] [Artivion Completes Acquisition of Endospan Ltd.](https://www.quantisnow.com/insight/artivion-completes-acquisition-of-endospan-ltd-6559034)
- 2026-05-15 19:13 UTC [SEC Form 8-K] [Artivion Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/artivion-inc-filed-sec-form-8-k-submission-of-matters-to-6556863)
- 2026-05-08 14:56 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Artivion Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-artivion-inc-6541459)
- 2026-05-07 20:10 UTC [SEC Form 8-K] [Artivion Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/artivion-inc-filed-sec-form-8-k-entry-into-a-material-6539104)
- 2026-05-07 20:05 UTC [Earnings Date] [Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan](https://www.quantisnow.com/insight/artivion-reports-first-quarter-2026-financial-results-and-announces-exercise-6538813)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AORT
- Earnings history: https://www.quantisnow.com/earnings/AORT
- Dividend history: https://www.quantisnow.com/dividends/AORT
- Insider transactions: https://www.quantisnow.com/insiders/AORT
- Options chain: https://www.quantisnow.com/options/AORT
- SEC 8-K filings only: https://www.quantisnow.com/company/AORT/8-k
- RSS and alerts for AORT: https://www.quantisnow.com/docs/rss-feeds.md
